Texmaco Rail & Engineering: Gets ₹4.71 Crore Letter Of Intent From Mangalore Coal Terminal.

TVS Motor: Launches Nepal's Most Powerful TVS Apache RTR 160 4V, Expanding Premium Motorcycle Range In Nepal.

Vikran Engineering: Cancels ₹354.21 Crore Solar EPC Order Due To Client Delays And Project Readiness Issues, Impacting Viability But No Significant Business Effect.

Kothari Industrial Corporation: Company Gets LOA from ICF Chennai for Forklift Services with Drivers, Fuel, and Support Staff for Coach Movement, Worth Around ₹9.45 Crore.

Patel Integrated Logistics: Changes Buyback Terms To ₹20 Per Share, Reduces Buyback Size To 54 Lakh Shares From 60 Lakh Shares.

Aurobindo Pharma: US FDA Inspection Ends With Two Noted Issues, Response Due Within Required Timeframe.

Persistent Systems: Company And Nagarro Enter Agreement To Create Persistent-Nagarro Group For AI-Driven Digital Engineering

Indoco Remedies: Co' Goa Facility Gets EU GMP Certification From Malta Medicines Authority.

Refex Industries: Company Secures ₹21.15 Crore Ash Transportation Contract From Maharatna CPSE.

Alembic Pharma: Co. Gets Final USFDA Approval For Oral Suspension Oseltamivir Phosphate, Which Has Annual US Sales Of $27 Million

BEML: Gets Extra $5.35 Million Export Order, Total Contract Now At $41.73 Million

Zydus Life: Forms Joint Venture With Sunshine Healthcare Lanka For 50% Stake In Zydus Sunshine Lifesciences With Investment Up To USD 5 Million.

Jubilant Pharmova: Company Unit Gets Tentative USFDA Approval For Pantoprazole Oral Suspension.

Aether Industries: Starts Manufacturing Operations At Site 5 In GIDC Panoli, Launching Two Blocks Of The First Phase. New Manufacturing Site Will Help Boost Production Capacity And Revenue Growth In The Upcoming Years.

Lupin: Company Gets Tentative Approval From U.S. FDA For Enzalutamide Tablets

Dr. Reddy's Labs: USFDA Finishes Pre-License Inspection Of Dr. Reddy's Labs' Biologics Manufacturing In Hyderabad, Noting Seven Observations.

SEBI Requests Clarification On DRHP From Jio Platforms As IPO Approaches Final Approval - CNBC TV18